NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders.

NeuroMetrix, Inc. (Nasdaq: NURO)

NeuroMetrix is a commercial stage company that was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology.

The Company has three commercial products. DPNCheck® is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain.

The Company is based in Woburn, MA.

Our mission is to improve health through neurotechnology

Business Model

NeuroMetrix is driven to solve unmet healthcare needs in the worldwide neurology and pain markets. The company’s expertise in neurotechnology is applied to create meaningful innovation. NeuroMetrix’s high margin “razor / razor blade” approach supports efficient and steady top-line growth.